Taubert H - Search Results

1

Novel mdm2 splice variants identified in pediatric rhabdomyosarcoma tumors and cell lines.

Bartel F, Taylor AC, Taubert H, Harris LC. Bartel F, et al. Among authors: taubert h. Oncol Res. 2001;12(11-12):451-7. doi: 10.3727/096504001108747459. Oncol Res. 2001. PMID: 11939408

2

Alternative and aberrant splicing of MDM2 mRNA in human cancer.

Bartel F, Taubert H, Harris LC. Bartel F, et al. Among authors: taubert h. Cancer Cell. 2002 Jul;2(1):9-15. doi: 10.1016/s1535-6108(02)00091-0. Cancer Cell. 2002. PMID: 12150820 Free article. Review.

3

Growth reduction of a xenotransplanted human soft tissue sarcoma by MDM2 antisense therapy via implanted osmotic minipumps.

Würl P, Bartel F, Meye A, Kappler M, Bache M, Schmidt H, Schönfelder M, Taubert H. Würl P, et al. Among authors: taubert h. Int J Oncol. 2002 May;20(5):1087-93. Int J Oncol. 2002. PMID: 11956608

4

MDM2 and its splice variant messenger RNAs: expression in tumors and down-regulation using antisense oligonucleotides.

Bartel F, Harris LC, Würl P, Taubert H. Bartel F, et al. Among authors: taubert h. Mol Cancer Res. 2004 Jan;2(1):29-35. Mol Cancer Res. 2004. PMID: 14757843 Review.

5

Alternate splicing of the p53 inhibitor HDMX offers a superior prognostic biomarker than p53 mutation in human cancer.

Lenos K, Grawenda AM, Lodder K, Kuijjer ML, Teunisse AF, Repapi E, Grochola LF, Bartel F, Hogendoorn PC, Wuerl P, Taubert H, Cleton-Jansen AM, Bond GL, Jochemsen AG. Lenos K, et al. Among authors: taubert h. Cancer Res. 2012 Aug 15;72(16):4074-84. doi: 10.1158/0008-5472.CAN-12-0215. Epub 2012 Jun 14. Cancer Res. 2012. PMID: 22700878

6

A MboII polymorphism in exon 11 of the human MDM2 gene occuring in normal blood donors and in soft tissue sarcoma patients: an indication for an increased cancer susceptibility?

Taubert H, Kappler M, Meye A, Bartel F, Schlott T, Lautenschläger C, Bache M, Schmidt H, Würl P. Taubert H, et al. Mutat Res. 2000 Nov 30;456(1-2):39-44. doi: 10.1016/s0027-5107(00)00112-3. Mutat Res. 2000. PMID: 11087894

7

Amplification of the MDM2 gene, but not expression of splice variants of MDM2 MRNA, is associated with prognosis in soft tissue sarcoma.

Bartel F, Meye A, Würl P, Kappler M, Bache M, Lautenschläger C, Grünbaum U, Schmidt H, Taubert H. Bartel F, et al. Among authors: taubert h. Int J Cancer. 2001 May 20;95(3):168-75. doi: 10.1002/1097-0215(20010520)95:3<168::aid-ijc1029>3.0.co;2-a. Int J Cancer. 2001. PMID: 11307150

8

Expression of alternatively and aberrantly spliced transcripts of the MDM2 mRNA is not tumor-specific.

Bartel F, Pinkert D, Fiedler W, Kappler M, Würl P, Schmidt H, Taubert H. Bartel F, et al. Among authors: taubert h. Int J Oncol. 2004 Jan;24(1):143-51. doi: 10.3892/ijo.24.1.143. Int J Oncol. 2004. PMID: 14654951

9

High bad and bcl-xL gene expression and combined bad, bcl-xL, bax and bcl-2 mRNA levels: molecular predictors for survival of stage 2 soft tissue sarcoma patients.

Köhler T, Würl P, Meye A, Lautenschläger C, Bartel F, Borchert S, Bache M, Schmidt H, Holzhausen HJ, Taubert H. Köhler T, et al. Among authors: taubert h. Anticancer Res. 2002 May-Jun;22(3):1553-9. Anticancer Res. 2002. PMID: 12168836

10

Loss of heterozygosity at 12q14-15 often occurs in stage I soft tissue sarcomas and is associated with MDM2 amplification in tumors at various stages.

Taubert H, Schuster K, Brinck U, Bartel F, Kappler M, Lautenschläger C, Bache M, Trump C, Schmidt H, Holzhausen HJ, Würl P, Schlott T. Taubert H, et al. Mod Pathol. 2003 Nov;16(11):1109-16. doi: 10.1097/01.MP.0000096045.51700.66. Mod Pathol. 2003. PMID: 14614050

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

460 results

Search Page

Filters